Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2020

01-08-2020 | COVID-19 | Health Services Research and Global Oncology

Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change

Authors: E. Shelley Hwang, MD, MPH, Charles M. Balch, MD, Glen C. Balch, MD, Sheldon M. Feldman, MD, Mehra Golshan, MD MBA, Stephen R. Grobmyer, MD, Steven K. Libutti, MD, Julie A. Margenthaler, MD, Madhu Sasidhar, MD, Kiran K. Turaga, MD, MPH, Sandra L. Wong, MD, MS, Kelly M. McMasters, MD, PhD, Kenneth K. Tanabe, MD

Published in: Annals of Surgical Oncology | Issue 8/2020

Login to get access

Abstract

Background

The COVID-19 pandemic has posed extraordinary demands from patients, providers, and health care systems. Despite this, surgical oncologists must maintain focus on providing high-quality, empathetic care for the almost 2 million patients nationally who will be diagnosed with operable cancer this year. The focus of hospitals is transitioning from initial COVID-19 preparedness activities to a more sustained approach to cancer care.

Methods

Editorial Board members provided observations of the implications of the pandemic on providing care to surgical oncology patients.

Results

Strategies are presented that have allowed institutions to successfully prepare for cancer care during COVID-19, as well as other strategies that will help hospitals and surgical oncologists manage anticipated challenges in the near term. Perspectives are provided on: (1) maintaining a safe environment for surgical oncology care; (2) redirecting the multidisciplinary model to guide surgical decisions; (3) harnessing telemedicine to accommodate requisite physical distancing; (4) understanding interactions between SARS CoV-2 and cancer therapy; (5) considering the ethical impact of professional guidelines for surgery prioritization; and (6) advocating for our patients who require oncologic surgery in the midst of the COVID-19 pandemic.

Conclusions

Until an effective vaccine becomes available for widespread use, it is imperative that surgical oncologists remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic will continue to impose on all of us.
Literature
1.
2.
Carolan A. Conversation with the cancer letter. What to expect: oncology’s response to coronavirus in Italy. Cancer Lett. 1919 March 11. 2020.
3.
4.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Int. Med. 2020;172:577-582.PubMedCrossRef
5.
Cook TM. Personal protective equipment during the COVID-19 pandemic—a narrative review. Anaesthesia. 2020.
6.
Hsu T. Where thousands of masks a day are decontaminated to battle the virus. The New York Times. 2020 April 11.
7.
Tate C. Hilton, Marriott donate free hotel rooms for medical workers responding to coronavirus crisis. USA Today. 2020.
8.
9.
10.
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976.PubMedPubMedCentralCrossRef
11.
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Cancer Netw. 2020;18(4):1–4.
12.
13.
Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, et al. Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol. 2020;27:1717–20.PubMedCrossRefPubMedCentral
14.
15.
16.
17.
Yang S, Cao P, Du P, Wu Z, Zhuang Z, Yang L, et al. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis. Ann Transl Med. 2020;8(4):128.PubMedPubMedCentralCrossRef
18.
Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020.
19.
20.
Mazzaferro V, Danelli P, Torzilli G, Busset MDD, Virdis M, Sposito C. A combined approach to priorities of surgical oncology during the COVID-19 epidemic. Ann Surg. 2020.
21.
Kane CK, Gillis K. The use of telemedicine by physicians: still the exception rather than the rule. Health Aff (Millwood). 2018;37(12):1923–30.CrossRef
22.
23.
Asiri A, AlBishi S, AlMadani W, ElMetwally A, Househ M. The use of telemedicine in surgical care: a systematic review. Acta Inform Med. 2018;26(3):201–6.PubMedPubMedCentralCrossRef
24.
25.
26.
27.
Shankar A, Saini D, Roy S, Mosavi Jarrahi A, Chakraborty A, Bharti SJ, et al. Cancer care delivery challenges amidst coronavirus disease—19 (COVID-19) outbreak: specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pac J Cancer Prev. 2020;21(3):569–73.PubMedCrossRefPubMedCentral
28.
29.
30.
Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020;12:269–73PubMedCrossRef
31.
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–34.PubMedPubMedCentralCrossRef
32.
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4.PubMedPubMedCentralCrossRef
33.
Yuen E, Fote G, Horwich P, Nguyen SA, Patel R, Davies J, et al. Head and neck cancer care in the COVID-19 pandemic: a brief update. Oral Oncol. 2020;105:104738.PubMedPubMedCentralCrossRef
34.
35.
Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3–16.PubMedCrossRef
36.
37.
38.
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–30.PubMedPubMedCentralCrossRef
39.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7.PubMedPubMedCentralCrossRef
40.
41.
Grass F, Behm KT, Duchalais E, Crippa J, Spears GM, Harmsen WS, et al. Impact of delay to surgery on survival in stage I-III colon cancer. Eur J Surg Oncol. 2020;46(3):455–61.PubMedCrossRef
42.
Metadata
Title
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
Authors
E. Shelley Hwang, MD, MPH
Charles M. Balch, MD
Glen C. Balch, MD
Sheldon M. Feldman, MD
Mehra Golshan, MD MBA
Stephen R. Grobmyer, MD
Steven K. Libutti, MD
Julie A. Margenthaler, MD
Madhu Sasidhar, MD
Kiran K. Turaga, MD, MPH
Sandra L. Wong, MD, MS
Kelly M. McMasters, MD, PhD
Kenneth K. Tanabe, MD
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 8/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08673-6

Other articles of this Issue 8/2020

Annals of Surgical Oncology 8/2020 Go to the issue

Health Services Research and Global Oncology

The Influence of Comorbidity on Health-Related Quality of Life After Esophageal Cancer Surgery

Hepatobiliary Tumors

The Landmark Series: Gallbladder Cancer

Peritoneal Surface Malignancy

Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

ASO Author Reflections

ASO Author Reflections: Expert Surgical Evaluation is Critical for Patients with Diffuse Malignant Peritoneal Mesothelioma: Lessons Learned from Assessing Outcomes of 2000 Patients

ASO Author Reflections

ASO Author Reflections: MRI-Derived Biomarker to Select Optimal Treatment for Esophageal Cancer Patients

Melanoma

Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study